Clinical benefits and pharmacology of scutellarin: A comprehensive review.
作者： Liping Wang , Qiang Ma
DOI: 10.1016/J.PHARMTHERA.2018.05.006
关键词: Pharmacotherapy 、 Stroke 、 Ischemia 、 Myocardial infarction 、 Platelet activation 、 Pharmacology 、 Context (language use) 、 Scutellarin 、 Reperfusion injury 、 Medicine
摘要: … of scutellarin with improved bioavailability, efficacy, and safety. Here we review the current literature on scutellarin … , and therapeutic potential of scutellarin for the treatment of ischemia, …
sci-hub.se 参考文章(150)
Yafeng Li, Shoucui Gao, Daxin Cheng, Sihai Zhao, Enqi Liu, Chuan Wang, Breviscapine Injection Improves the Therapeutic Effect of Western Medicine on Angina Pectoris Patients. PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0129969
Wei-Wei Wang, Lin Lu, Tian-Hao Bao, Hong-Miao Zhang, Jing Yuan, Wei Miao, Shu-Fen Wang, Zhi-Cheng Xiao, Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells. Journal of Molecular Neuroscience. ,vol. 58, pp. 210- 220 ,(2016) , 10.1007/S12031-015-0660-0
Wenjuan Wang, Xiaotang Ma, Jichun Han, Mingjie Zhou, Huanhuan Ren, Qunwen Pan, Chunli Zheng, Qiusheng Zheng, Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor PLOS ONE. ,vol. 11, pp. e0146197- ,(2016) , 10.1371/JOURNAL.PONE.0146197
Zhou Wang, Jingui Yu, Jianbo Wu, Feng Qi, Huanliang Wang, Zhigang Wang, Zhijie Xu, Scutellarin protects cardiomyocyte ischemia-reperfusion injury by reducing apoptosis and oxidative stress. Life Sciences. ,vol. 157, pp. 200- 207 ,(2016) , 10.1016/J.LFS.2016.01.018
Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity. Chinese Journal of Physiology. ,vol. 54, pp. 399- 405 ,(2011) , 10.4077/CJP.2011.AMM059
Yungxia He, Gang Cheng, J E Yu, Fude Cui, Xinhua Hao, Feng An, Jin Sun, Study on the role of hepatic first-pass elimination in the low oral bioavailability of scutellarin in rats. Pharmazie. ,vol. 60, pp. 477- 478 ,(2005)
Li Zhou, Sheng-nan Guo, Ying Gao, Effects and Perspectives of Chinese Patent Medicines for Tonifying Qi and Promoting Blood Circulation on Patients with Cerebral Infarction Current Vascular Pharmacology. ,vol. 13, pp. 475- 491 ,(2015) , 10.2174/1570161112666141014150232
Lin Li, Lu Li, Chen Chen, Jian Yang, Jiaxun Li, Na Hu, Yang Li, Dongmei Zhang, Tao Guo, Xuan Liu, Weimin Yang, Scutellarin’s Cardiovascular Endothelium Protective Mechanism: Important Role of PKG-Iα PLOS ONE. ,vol. 10, pp. e0139570- ,(2015) , 10.1371/JOURNAL.PONE.0139570
Xiaoxuan Tian, Lianying Chang, Guangyin Ma, Taiyi Wang, Ming Lv, Zhilong Wang, Liping Chen, Yuefei Wang, Xiumei Gao, Yan Zhu, Delineation of platelet activation pathway of Scutellarein revealed its intracellular target as Protein Kinase C Biological & Pharmaceutical Bulletin. ,vol. 39, pp. 181- 191 ,(2016) , 10.1248/BPB.B15-00511
HS You, Absorption and transportation characteristics of scutellarin and scutellarein across Caco-2 monolayer model Journal of Chinese Integrative Medicine. ,vol. 8, pp. 863- 869 ,(2010) , 10.3736/JCIM20100910